Crestwood Advisors Group LLC Medtronic PLC Transaction History

Crestwood Advisors Group LLC

  • $5.07 Billion
  • Q1 2025

A detailed history of Crestwood Advisors Group LLC transactions in Medtronic PLC stock. As of the latest transaction made, Crestwood Advisors Group LLC holds 6,935 shares of MDT stock, worth $599,461. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,935
Previous 6,524 6.3%
Holding current value
$599,461
Previous $521,000 19.58%
% of portfolio
0.01%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 05, 2025
BUY
$79.84 - $94.5 $32,814 - $38,839
411 Added 6.3%
6,935 $623,000
Q4 2024

Feb 04, 2025
SELL
$79.61 - $92.24 $44,979 - $52,115
-565 Reduced 7.97%
6,524 $521,000
Q3 2024

Oct 30, 2024
BUY
$76.84 - $91.03 $40,341 - $47,790
525 Added 8.0%
7,089 $638,000
Q2 2024

Aug 01, 2024
SELL
$78.71 - $87.02 $51,004 - $56,388
-648 Reduced 8.99%
6,564 $516,000
Q1 2024

May 08, 2024
BUY
$82.84 - $88.09 $140,082 - $148,960
1,691 Added 30.63%
7,212 $628,000
Q4 2023

Jan 29, 2024
BUY
$69.43 - $83.43 $43,254 - $51,976
623 Added 12.72%
5,521 $454,000
Q3 2023

Nov 15, 2023
BUY
$78.22 - $90.4 $161,680 - $186,856
2,067 Added 73.01%
4,898 $383,000
Q2 2023

Aug 15, 2023
BUY
$79.47 - $91.38 $20,026 - $23,027
252 Added 9.77%
2,831 $249,000
Q1 2023

May 12, 2023
SELL
$76.72 - $87.58 $3,452 - $3,941
-45 Reduced 1.71%
2,579 $207,000
Q4 2022

Feb 14, 2023
BUY
$76.18 - $87.74 $6,551 - $7,545
86 Added 3.39%
2,624 $203,000
Q3 2022

Oct 26, 2022
SELL
$80.75 - $95.31 $182,252 - $215,114
-2,257 Reduced 47.07%
2,538 $205,000
Q2 2022

Jul 07, 2022
BUY
$87.4 - $113.09 $27,006 - $34,944
309 Added 6.89%
4,795 $430,000
Q1 2022

Apr 12, 2022
SELL
$100.58 - $112.38 $11.3 Million - $12.6 Million
-111,927 Reduced 96.15%
4,486 $498,000
Q4 2021

Feb 15, 2022
SELL
$99.53 - $127.75 $24 Million - $30.8 Million
-241,065 Reduced 67.43%
116,413 $12 Million
Q3 2021

Nov 03, 2021
BUY
$122.75 - $135.17 $57,078 - $62,854
465 Added 0.13%
357,478 $44.8 Million
Q2 2021

Aug 13, 2021
BUY
$118.19 - $131.5 $961,239 - $1.07 Million
8,133 Added 2.33%
357,013 $44.3 Million
Q1 2021

Apr 21, 2021
BUY
$111.18 - $119.74 $1.47 Million - $1.58 Million
13,223 Added 3.94%
348,880 $41.2 Million
Q4 2020

Feb 09, 2021
BUY
$100.57 - $117.14 $2.69 Million - $3.14 Million
26,765 Added 8.66%
335,657 $39.3 Million
Q3 2020

Oct 06, 2020
BUY
$90.13 - $108.78 $49,030 - $59,176
544 Added 0.18%
308,892 $32.1 Million
Q2 2020

Aug 14, 2020
BUY
$84.11 - $103.33 $892,659 - $1.1 Million
10,613 Added 3.56%
308,348 $28.3 Million
Q1 2020

May 15, 2020
BUY
$72.92 - $121.3 $1.24 Million - $2.07 Million
17,069 Added 6.08%
297,735 $26.9 Million
Q4 2019

Feb 12, 2020
BUY
$104.49 - $114.54 $669,467 - $733,857
6,407 Added 2.34%
280,666 $31.8 Million
Q3 2019

Nov 13, 2019
BUY
$98.02 - $111.18 $514,899 - $584,028
5,253 Added 1.95%
274,259 $29.8 Million
Q2 2019

Aug 14, 2019
BUY
$84.15 - $99.38 $567,675 - $670,417
6,746 Added 2.57%
269,006 $26.2 Million
Q1 2019

May 09, 2019
BUY
$82.45 - $93.79 $593,557 - $675,194
7,199 Added 2.82%
262,260 $23.9 Million
Q4 2018

Feb 14, 2019
BUY
$85.8 - $99.49 $245,130 - $284,242
2,857 Added 1.13%
255,061 $23.2 Million
Q3 2018

Nov 15, 2018
SELL
$85.91 - $99.17 $201,287 - $232,355
-2,343 Reduced 0.92%
252,204 $24.8 Million
Q2 2018

Aug 14, 2018
SELL
$77.48 - $87.83 $94,060 - $106,625
-1,214 Reduced 0.47%
254,547 $0
Q1 2018

May 14, 2018
BUY
$76.55 - $87.26 $705,025 - $803,664
9,210 Added 3.74%
255,761 $20.5 Million
Q4 2017

Jan 11, 2018
SELL
$76.93 - $83.5 $418,806 - $454,574
-5,444 Reduced 2.16%
246,551 $19.9 Million
Q3 2017

Nov 20, 2017
BUY
$77.71 - $84.6 $19.6 Million - $21.3 Million
251,995
251,995 $19.6 Million

Others Institutions Holding MDT

# of Institutions
2,440
Shares Held
1.05B
Call Options Held
10.3M
Put Options Held
9.61M
View Full List

About Medtronic plc

MDT Quotes by TradingView
  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Crestwood Advisors Group LLC Portfolio

Follow Crestwood Advisors Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crestwood Advisors Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email